Lichen China Limited (LICN)
NASDAQ: LICN · IEX Real-Time Price · USD
0.550
-0.430 (-43.88%)
Apr 23, 2024, 2:02 PM EDT - Market open

Lichen China Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Revenue
39.7633.8134.330.67
Revenue Growth (YoY)
17.61%-1.43%11.83%-
Cost of Revenue
15.4413.6113.8211.83
Gross Profit
24.3220.1920.4818.84
Selling, General & Admin
12.069.549.1810.05
Operating Expenses
12.069.549.1810.05
Operating Income
12.2610.6511.38.79
Other Expense / Income
0.67-0.09-0.22-0.21
Pretax Income
11.5910.7411.519
Income Tax
3.252.923.052.59
Net Income
8.347.828.466.41
Net Income Growth
6.65%-7.61%32.07%-
Shares Outstanding (Basic)
26232323
Shares Outstanding (Diluted)
26232323
Shares Change
15.88%---
EPS (Basic)
0.320.350.380.28
EPS (Diluted)
0.320.350.380.28
EPS Growth
-8.57%-7.89%35.71%-
Free Cash Flow
-7.258.827.878.35
Free Cash Flow Per Share
-0.280.390.350.37
Gross Margin
61.17%59.73%59.70%61.42%
Operating Margin
30.83%31.50%32.94%28.65%
Profit Margin
20.97%23.13%24.67%20.89%
Free Cash Flow Margin
-18.22%26.08%22.93%27.23%
Effective Tax Rate
28.05%27.22%26.51%28.78%
EBITDA
14.5813.4714.0511.24
EBITDA Margin
36.68%39.86%40.98%36.66%
Depreciation & Amortization
32.732.542.25
EBIT
11.5910.7411.519
EBIT Margin
29.15%31.78%33.57%29.33%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).